Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1986 May;88(1):231–237. doi: 10.1111/j.1476-5381.1986.tb09491.x

A comparison of the binding of sigma opioids and phencyclidine, and the interaction with antipsychotic drugs in rat brain membranes.

C P Downes, P E Lewis, M A Stone
PMCID: PMC1917098  PMID: 2871882

Abstract

The present study investigates the relationship between binding at the sigma site labelled by the prototypic sigma ligand (+)-[3H]-N-allylnormetazocine [+)-[3H]-SKF10,047) and binding at the phencyclidine (PCP) site labelled by [3H]-phencyclidine in rat whole brain membranes. (+)-[3H]-SKF10,047 bound with a KD of 251 +/- 66 nM. [3H]-PCP bound with a KD of 180 +/- 35 nM (KD +/- asymptotic s.e.). The potencies of a range of compounds to displace these ligands were only poorly correlated (r = 0.3). Furthermore selective displacement of (+)-[3H]-SKF10,047 but not of [3H]-PCP was demonstrated using the non-selective dopamine ligand haloperidol and the dopamine2-selective ligand 3-(3-hydroxyphenyl)N-n-propylpiperidine (3PPP). These results indicate that the sigma and PCP sites are different entities. The relationship between binding at the sigma site and dopamine receptors was investigated in rat whole brain membranes and in striatal membranes. (+/-)-SKF10,047 displaced [3H]-haloperidol bound to whole brain membranes with a greater potency than it displaced [3H]-haloperidol bound to striatal membranes. The opposite was true for the dopamine antagonist, clozapine, which showed greater potency in striatal membranes. Comparison of [3H]-haloperidol binding in whole brain and striatum gave only a poor correlation (r = 0.6). Hence, different binding sites would appear to exist in these brain regions, the binding of [3H]-haloperidol to whole brain being predominantly to sigma sites and the binding to striatum being predominantly to dopamine receptors.

Full text

PDF
231

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aceto M. D., May E. L. Antinociceptive studies of the optical isomers of N-allylnormetazocine (SKF 10,047). Eur J Pharmacol. 1983 Jul 22;91(2-3):267–272. doi: 10.1016/0014-2999(83)90476-4. [DOI] [PubMed] [Google Scholar]
  2. Holtzman S. G. Phencyclidine-like discriminative stimulus properties of opioids in the squirrel monkey. Psychopharmacology (Berl) 1982;77(4):295–300. doi: 10.1007/BF00432758. [DOI] [PubMed] [Google Scholar]
  3. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  4. Martin W. R., Eades C. G., Thompson J. A., Huppler R. E., Gilbert P. E. The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther. 1976 Jun;197(3):517–532. [PubMed] [Google Scholar]
  5. Murray T. F., Leid M. E. Interaction of dextrorotatory opioids with phencyclidine recognition sites in rat brain membranes. Life Sci. 1984 May 14;34(20):1899–1911. doi: 10.1016/0024-3205(84)90121-8. [DOI] [PubMed] [Google Scholar]
  6. Quirion R., Hammer R. P., Jr, Herkenham M., Pert C. B. Phencyclidine (angel dust)/sigma "opiate" receptor: visualization by tritium-sensitive film. Proc Natl Acad Sci U S A. 1981 Sep;78(9):5881–5885. doi: 10.1073/pnas.78.9.5881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Shannon H. E. Phencyclidine-like discriminative stimuli of (+)- and (-)-N-allylnormetazocine in rats. Eur J Pharmacol. 1982 Oct 22;84(3-4):225–228. doi: 10.1016/0014-2999(82)90207-2. [DOI] [PubMed] [Google Scholar]
  8. Tam S. W. (+)-[3H]SKF 10,047, (+)-[3H]ethylketocyclazocine, mu, kappa, delta and phencyclidine binding sites in guinea pig brain membranes. Eur J Pharmacol. 1985 Feb 12;109(1):33–41. doi: 10.1016/0014-2999(85)90536-9. [DOI] [PubMed] [Google Scholar]
  9. Tam S. W., Cook L. Sigma opiates and certain antipsychotic drugs mutually inhibit (+)-[3H] SKF 10,047 and [3H]haloperidol binding in guinea pig brain membranes. Proc Natl Acad Sci U S A. 1984 Sep;81(17):5618–5621. doi: 10.1073/pnas.81.17.5618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Tam S. W. Naloxone-inaccessible sigma receptor in rat central nervous system. Proc Natl Acad Sci U S A. 1983 Nov;80(21):6703–6707. doi: 10.1073/pnas.80.21.6703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Zukin R. S., Zukin S. R. Demonstration of [3H]cyclazocine binding to multiple opiate receptor sites. Mol Pharmacol. 1981 Sep;20(2):246–254. [PubMed] [Google Scholar]
  12. Zukin S. R., Brady K. T., Slifer B. L., Balster R. L. Behavioral and biochemical stereoselectivity of sigma opiate/PCP receptors. Brain Res. 1984 Feb 27;294(1):174–177. doi: 10.1016/0006-8993(84)91326-x. [DOI] [PubMed] [Google Scholar]
  13. Zukin S. R., Fitz-Syage M. L., Nichtenhauser R., Zukin R. S. Specific binding of [3H]phencyclidine in rat central nervous tissue: further characterization and technical considerations. Brain Res. 1983 Jan 10;258(2):277–284. doi: 10.1016/0006-8993(83)91151-4. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES